← Back to Clinical Trials
Recruiting NCT06985420

NCT06985420 The Effect of the Menstrual Cycle on Immune Cell Activity and Recovery After Resistance Exercise

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06985420
Status Recruiting
Phase
Sponsor University of Central Florida
Condition Healthy Women
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2024-08-16
Primary Completion 2025-05

Trial Parameters

Condition Healthy Women
Sponsor University of Central Florida
Study Type OBSERVATIONAL
Phase N/A
Enrollment 40
Sex FEMALE
Min Age 18 Years
Max Age 40 Years
Start Date 2024-08-16
Completion 2025-05
Interventions
Resistance exerciseMenstrual Cycle Phases

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this observational study is to learn how the menstrual cycle affects immune cell activation, recruitment, and recovery responses after resistance exercise in healthy, resistance-trained women aged 18-40. The main questions it aims to answer are: Does the menstrual cycle influence neutrophil recruitment and adhesion after resistance exercise? Does the menstrual cycle affect markers of muscle damage and functional recovery? Researchers will compare three menstrual phases (early follicular, late follicular, and mid-luteal) to see if immune responses and recovery outcomes differ across these phases. Participants will: Complete resistance exercise protocols across three different menstrual cycle phases. Provide blood samples to assess immune cell activation and muscle damage markers. Track sleep, mood, and recovery with questionnaires and wear an accelerometer.

Eligibility Criteria

Inclusion Criteria: * Women between the ages of 18 and 40. * Must weigh at least 110 pounds. * Healthy as determined by medical history, physical activity readiness, and menstrual cycle questionnaires. * Actively resistance training for at least 6 months (minimum of 3 resistance training sessions per week, with at least one lower body session). * Pre-menopausal and have a regular menstrual cycle (eumenorrheic), with a clear start of menses (early follicular phase). * Not currently pregnant or planning to become pregnant during the study. * Have not used hormonal birth control or intrauterine devices in the past 3 months (or three full menstrual cycles). * Able to recall approximate start dates of their last 6 menstrual cycles. * Willing to follow study instructions, including avoiding exercise, alcohol, and caffeine before testing visits. * Free from previous or current lower body injuries that could limit performance. * Not regularly taking any medications that could interfere with th

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology